Stefanie M. De Groot

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report.

Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report.

Journal: Case reports in ophthalmology

Published: November 22, 2023

IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial).

IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial).

Journal: Cancers

Published: October 25, 2023

Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer.

Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer.

Journal: Cancers

Published: December 23, 2022

Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.

Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.

Journal: International journal of cancer

Published: January 03, 2021

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma.

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma.

Journal: Cancers

Published: October 06, 2020

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.

Journal: Breast cancer research and treatment

Published: August 03, 2020

The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.

The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.

Journal: Scientific reports

Published: April 28, 2020

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.

Journal: Nature communications

Published: December 17, 2019

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).

Journal: Breast cancer research : BCR

Published: April 25, 2019

Effects of short-term fasting on cancer treatment.

Effects of short-term fasting on cancer treatment.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 23, 2019

Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients.

Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients.

Journal: Cancer management and research

Published: October 13, 2018

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy.

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy.

Journal: OncoTargets and therapy

Published: June 28, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026